Catalent ROE 2012-2018 | CTLT

Current and historical return on equity (ROE) values for Catalent (CTLT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Catalent ROE for the three months ending September 30, 2018 was 19.13%.
Catalent ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.07B $1.53B 5.63%
2018-06-30 $0.08B $1.09B 8.00%
2018-03-31 $0.06B $1.07B 6.57%
2017-12-31 $0.07B $1.01B 8.21%
2017-09-30 $0.11B $1.04B 14.56%
2017-06-30 $0.11B $0.72B 17.12%
2017-03-31 $0.11B $0.64B 17.08%
2016-12-31 $0.09B $0.59B 14.91%
2016-09-30 $0.11B $0.62B 17.07%
2016-06-30 $0.11B $0.64B 18.34%
2016-03-31 $0.21B $0.60B 34.08%
2015-12-31 $0.23B $0.61B 39.72%
2015-09-30 $0.25B $0.60B 44.73%
2015-06-30 $0.21B $0.63B 40.63%
2015-03-31 $0.09B $0.47B 31.53%
2014-12-31 $0.06B $0.49B 109.42%
2014-09-30 $-0.01B $0.50B 2.95%
2014-06-30 $0.02B $-0.37B -5.75%
2014-03-31 $-0.01B $-0.40B 3.28%
2013-12-31 $-0.02B $-0.41B 8.29%
2013-09-30 $0.00B $0.00B -1.05%
2013-06-30 $0.00B $-0.41B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.466B $2.463B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.572B 11.48
Zoetis (ZTS) United States $42.477B 29.08
Grifols (GRFS) Spain $14.128B 17.24
Tilray (TLRY) United States $9.687B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.785B 12.61
Neurocrine Biosciences (NBIX) United States $8.024B 1769.80
Ionis Pharmaceuticals (IONS) United States $7.331B 0.00
Nektar Therapeutics (NKTR) United States $6.598B 9.46
Impax Laboratories (AMRX) United States $5.553B 29.52
Sage Therapeutics (SAGE) United States $5.035B 0.00
United Therapeutics (UTHR) United States $4.935B 8.07
Loxo Oncology (LOXO) United States $4.516B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.906B 14.46
FibroGen (FGEN) United States $3.346B 0.00
USANA Health Sciences (USNA) United States $2.872B 24.44
Endo (ENDP) Ireland $2.811B 4.31
TESARO (TSRO) United States $2.338B 0.00
Xencor (XNCR) United States $2.113B 0.00
Endocyte (ECYT) United States $1.935B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.888B 255.06
Aerie Pharmaceuticals (AERI) United States $1.866B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.838B 0.00
Heron Therapeutics (HRTX) United States $1.816B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.755B 0.00
Zogenix (ZGNX) United States $1.692B 0.00
PTC Therapeutics (PTCT) United States $1.619B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.552B 18.97
Corcept Therapeutics (CORT) United States $1.415B 20.76
Theravance Biopharma (TBPH) Cayman Islands $1.374B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.360B 0.00
Portola Pharmaceuticals (PTLA) United States $1.281B 0.00
Esperion Therapeutics (ESPR) United States $1.225B 0.00
Tricida (TCDA) United States $1.221B 0.00
TherapeuticsMD (TXMD) United States $1.149B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.083B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.954B 0.00
ImmunoGen (IMGN) United States $0.796B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.730B 0.00
Radius Health (RDUS) United States $0.706B 0.00
Karyopharm Therapeutics (KPTI) United States $0.620B 0.00
Flexion Therapeutics (FLXN) United States $0.596B 0.00
Collegium Pharmaceutical (COLL) United States $0.570B 0.00
GlycoMimetics (GLYC) United States $0.510B 0.00
ChemoCentryx (CCXI) United States $0.482B 38.12
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.452B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.435B 0.00
Dermira (DERM) United States $0.425B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Xeris Pharmaceuticals (XERS) United States $0.412B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.409B 24.13
Forty Seven (FTSV) United States $0.397B 0.00
Akebia Therapeutics (AKBA) United States $0.396B 0.00
Odonate Therapeutics (ODT) United States $0.395B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.387B 0.00
OptiNose (OPTN) United States $0.386B 0.00
ArQule (ARQL) United States $0.386B 0.00
CASI Pharmaceuticals (CASI) United States $0.379B 0.00
Aclaris Therapeutics (ACRS) United States $0.351B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Zafgen (ZFGN) United States $0.343B 0.00
Depomed (ASRT) United States $0.343B 12.76
KalVista Pharmaceuticals (KALV) United States $0.340B 0.00
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Minerva Neurosciences (NERV) United States $0.327B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.317B 0.00
Translate Bio (TBIO) United States $0.316B 0.00
Aratana Therapeutics (PETX) United States $0.311B 0.00
Mast Therapeutics (SVRA) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.291B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.287B 0.00
Tapimmune (MRKR) United States $0.284B 0.00
Majesco Entertainment (PTE) United States $0.276B 0.00
Affimed (AFMD) Germany $0.267B 0.00
IMV INC (IMV) Canada $0.248B 0.00
Lannett Co Inc (LCI) United States $0.226B 1.97
Aldeyra Therapeutics (ALDX) United States $0.222B 0.00
Tyme Technologies (TYME) United States $0.221B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Opexa Therapeutics (ACER) United States $0.210B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.210B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.206B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.199B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.193B 0.00
MEI Pharma (MEIP) United States $0.191B 0.00
Neon Therapeutics (NTGN) United States $0.180B 0.00
Calithera Biosciences (CALA) United States $0.180B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.176B 0.00
Ardelyx (ARDX) United States $0.176B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 0.00
ElectroCore (ECOR) United States $0.169B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
Redhill Biopharma (RDHL) Israel $0.162B 0.00
ContraFect (CFRX) United States $0.160B 0.00
MediWound (MDWD) Israel $0.155B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Melinta Therapeutics (MLNT) United States $0.143B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Recro Pharma (REPH) United States $0.138B 0.00
DURECT (DRRX) United States $0.135B 0.00
Adherex Technologies (FENC) United States $0.133B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.123B 0.00
ProNAi Therapeutics (SRRA) Canada $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.117B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.108B 0.00
Rafael Holdings (RFL) United States $0.105B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.095B 0.00
CTI BioPharma (CTIC) United States $0.090B 0.00
Achaogen (AKAO) United States $0.090B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.079B 0.00
Infinity Pharmaceuticals (INFI) United States $0.077B 0.00
Otonomy (OTIC) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.94
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
KemPharm (KMPH) United States $0.063B 0.00
Immune Design (IMDZ) United States $0.063B 0.00
Forward Pharma (FWP) Denmark $0.063B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 35.00
Novan (NOVN) United States $0.055B 0.00
Neos Therapeutics (NEOS) United States $0.052B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.048B 0.00
Heat Biologics (HTBX) United States $0.048B 0.00
Capnia (SLNO) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Trillium Therapeutics (TRIL) Canada $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.038B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.94
Lipocine (LPCN) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
HANCOCK JAFFE (HJLI) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.65
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.017B 0.00
Shineco (TYHT) China $0.016B 1.58
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Bio-Path Holdings (BPTH) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
PharmAthene (ALT) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00